Clinical Trial Update: Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a CD19-targeted CAR-T cell therapy in adults with refractory systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• CD19-targeted CAR-T cell therapy

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Systemic Lupus Erythematosus (SLE), Refractory | Phase 1 | Status: RECRUITING